Keywords = HCV
| Number of Articles: 238 | ||||
| 101 | Interleukin-9: Investigating its possible role in liver cirrhosis progression and in tumour promotion of hepatocellular carcinoma in chronic HCV infected patients, A single centre study | |||
| Volume 2, Issue 2, May 2021, Page 260-270 | ||||
| Amira Esmail Abdelhamid; Shimaa Ahmed Abdel Salam; Heba Ahmed Faheem; Ossama Ashraf Ahmed; Manar Mohamed Salah; Heba Ismail Aly | ||||
| 102 | Role of Interleukin-28 B Gene Polymorphism and Cytomegalovirus Coinfection in Hepatocellular Carcinoma Patients with Chronic Hepatitis C Virus | |||
| Volume 30, Issue 2, April 2021, Page 99-106 | ||||
| Fatma Omar Khalil | ||||
| 103 | The Effect of Direct Acting Antiviral Therapy for Hepatitis C- Virus Infected Egyptian Patients on Changes in the Parameters of Liver Fibrosis Progression | |||
| Volume 41, Issue 2, April 2021, Page 203-219 | ||||
| Mohamed A. Elfiki; Mahmoud Farid; Ayman Soliman; Bishoy A. Ibrahim | ||||
| 104 | Impact of Hepatitis C virus Infection and direct-acting Oral Antiviral Drugs on glycaemic state in Type 2 Diabetic Patients | |||
| Volume 38, Issue 1, April 2021, Page 185-195 | ||||
| Ayman ElBadawy; Mohamed ElSayed; Islam Abdullatif; Rasha AbdelMoneim | ||||
| 105 | Association of Hepatitis C viral load with liver functions and risk factors among HCV patients, Minia governorate, Egypt | |||
| Volume 5, Issue 1, January and February 2021, Page 1118-1131 | ||||
| Hala R. Ahmed; Reham A. Ibrahem; Rehab M. Abd El-Baky; Helal F. Hetta; Amr M. Elsayed; Nancy G. F. M. Waly | ||||
| 106 | Outcome of Decompensated Hepatitis C Virus Cirrhotic Patients Treated with Direct Acting Antiviral Drugs | |||
| Volume 27, Issue 1, January 2021, Page 70-80 | ||||
| Amir Ahmed; Sahar Gouda Zagloul; Hoda Abdel-aziz El-hady; Ahmed Fathy Gomaa | ||||
| 107 | Do Sofosbuvir and Daclatasvir Affect Vitamin D and Iron Status in Chronic Hepatitis C Virus Patients? Role of Hepcidin | |||
| Volume 41, Issue 1, January 2021, Page 15-27 | ||||
| Eman S. H. Abd Allah; Safinaz Hussein; Rania Hafez; Hussein A. El-amin | ||||
| 108 | IMPACT OF TREATMENT WITH DIRECT ACTING ANTIVIRAL AGENTS (DAAS) ON MIXED CRYOGLOBULINEMIA OF HCV EGYPTIAN PATIENTS | |||
| Volume 50, Issue 1, January 2021, Page 719-732 | ||||
| Karim Elnoemany; Mohamed H. El-Nadry; Sayed F. Mohamed; Mohamed M. Abd El-Halim | ||||
| 109 | MEASUREMENT OF SERUM BIOCHEMICAL LIVER PARAMETERS AND HCV RNA LEVELS FOR DETECTION THE SEVERITY OF HEPATITIS C VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA | |||
| Volume 26, Issue 1, January 2021, Page 97-106 | ||||
| Mohamed Ebeid; Ibrahim El Sayed; Ismail Hegzy; Maha El Mansy; Samah Mamdouh; Fatma Khorshed; Maysa Abd Rabou | ||||
| 110 | Effect of Direct Acting Anti-Hepatitis C Drugs on the Heart | |||
| Volume 82, Issue 1, January 2021, Page 106-114 | ||||
| Mohamed Mahmoud Ahmed; Muhammad Abdel-Gawad; Mahmoud Ahmed Abd elbaset; Assem Elkady | ||||
| 111 | Gene silencing approaches for the treatment of hepatitis C virus infection | |||
| Volume 4, Issue 1, January 2021, Page 42-44 | ||||
| hossein elbadawy; Naif Aljuhani | ||||
| 112 | Impact of gene polymorphism on Egyptian HCV patients under direct antiviral Drugs | |||
| Volume 16, Issue 1, 2020, Page 109-119 | ||||
| Soha M. Hamdy; Sara H. A. Agwa; Ahmed A. G. Afify; Amany M. Mohmmed; Basma M. M. Ali | ||||
| 113 | Serum Inducible Protein -10 chemokine as a biomarker for clearance of HCV with and without treatment in Egyptian patients | |||
| Volume 16, Issue 1, 2020, Page 63-78 | ||||
| Faten Z. Mohammed; Ashraf A. Tabll; Reem Elshnawy; Hazem S. Elsharkawy | ||||
| 114 | Association Between the ACE (I/D) Gene Polymorphism and Hepatocellular Carcinoma Risk in Egyptian HCV Patients | |||
| Volume 4, Issue 3, December 2020, Page 159-167 | ||||
| Naglaa Said Elabd; Belal Montaser; Heba khader; Suzy Gohar; Khalid Makboul; Moamena Elhamoly | ||||
| 115 | HCC Incidence in DAAs-Treated and Untreated Egyptian HCV-Infected Patients | |||
| Volume 10, Issue 4, December 2020, Page 346-355 | ||||
| Mohammed Alaa El-Din Nouh; Mahmoud Mohammed Moawad Sera; Ahmed Ragab El-Gazzarah | ||||
| 116 | Prevalence of occult HCV infections in Saudi patients who achieved sustained virologic response with direct acting antiviral treatment | |||
| Volume 5.1, Issue 1, November 2020, Page 7-12 | ||||
| Hamad Al Ashgar; Mohammed Al Quaiz; Khalid Al Kahtani; Ahmed AlQahtani; Hussa Alhussaini; Amr M Elssadany; Saleh A Alqahtani; MUSTHAFA PEEDIKAYIL | ||||
| 117 | IRON HOMEOSTASIS REGULATING FACTORS IN HEPATITIS C | |||
| Volume 35, Issue 11, November and December 2020, Page 174-187 | ||||
| 118 | EPIDERMAL GROWTH FACTOR GENE POLYMORPHISM IN CIRRHOTIC HEPATITIS C VIRUS PATIENTS WITH HEPATOCELLULER CARCINOMA | |||
| Volume 2, Issue 2, October 2020, Page 76-76 | ||||
| Nehal Elsayed Bahnasy | ||||
| 119 | Assessment of Adrenal Function in Chronic Hepatitis C Patients | |||
| Volume 31, Issue 4, October 2020, Page 39-42 | ||||
| Hala M. Hosny; Mohammed E. A.; Yehia Z. Mahmoud; Hend H. Moenes; Adel N. M. | ||||
| 120 | Cost Minimization of Pre-Enrolment Investigations in Treating HCV Infected Patients | |||
| Volume 38, Issue 4, October 2020, Page 87-99 | ||||
| 121 | Role of High Mobility Group Box1 in Pathogenesis of Hepatitis C Virus induced Hepatocellular Carcinoma | |||
| Volume 29, Issue 4, October 2020, Page 135-141 | ||||
| Nouran E. Samra; Shahira El-Etreby; Rasha H. El- Mahdy; Samah S. El-Kazzaz; Nariman M. El-Nashar | ||||
| 122 | Assessment of Right Liver Lobe Size / Serum Albumin Ratio as a New Non-Invasive Predictor for the Presence of Oesophageal Varices in Egyptian Patients with HCV Related Liver Cirrhosis | |||
| Volume 81, Issue 5, October 2020, Page 2016-2025 | ||||
| Emad Ahmad Awad; Wael Ahmed Yousry; Hasan Mokhtar Hasan; Ahmed Mohamed ElGhandour | ||||
| 123 | Outcome of Direct Acting Antiviral Drugs (DAADs) for Hepatitis C Virus (HCV) in the Setting of Chronic Kidney Disease (CKD) in Upper Egypt | |||
| Volume 81, Issue 5, October 2020, Page 2012-2015 | ||||
| Iman Ibrahim Sarhan; Mohamed Mostafa Ali; Ahmed Abd Elmonem Hassan; Mostafa Abd Elnasier Abd Elgawad | ||||
| 124 | A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs | |||
| Volume 1, Issue 9, September 2020, Page 256-260 | ||||
| Moataz Mostafa Mousa; Magdy A. Elkerim El Dahshan; Arafat A. Elazem Qasem; Wael Refaat Hablas | ||||
| 125 | Efficacy of Sofosbuvir-Daclatasvir in Treatment of Chronic Hepatitis C Virus Infection | |||
| Volume 5, Issue 6 part (2), September 2020, Page 241-251 | ||||
| Y.S. Younis; T.E. Elazab; E.M. Abd El-Fattah | ||||
| | ||||
View on SCiNiTO
